Febushine Tablet contains Febuxostat 40mg, a medication primarily used to manage hyperuricemia in patients with gout. Febuxostat is a xanthine oxidase inhibitor that works by reducing the production of uric acid in the body, thereby preventing gout attacks and complications associated with elevated uric acid levels such as joint pain, inflammation, and tophi formation. It is typically prescribed for individuals who have not responded well to other urate-lowering therapies like allopurinol or those who have contraindications to such treatments. Febushine is taken orally, usually once daily, with or without food, and the dosage may be adjusted based on serum uric acid levels and clinical response. Patients are advised to maintain adequate hydration and follow dietary recommendations to optimize treatment outcomes. Common side effects may include nausea, joint pain, rash, and liver enzyme abnormalities, so regular monitoring of liver function and uric acid levels is recommended during therapy. Febushine should be used cautiously in patients with cardiovascular disease or liver impairment. It is important to inform healthcare providers of any other medications being taken to avoid potential drug interactions. Overall, Febushine Tablet is an effective option for long-term management of gout and hyperuricemia under medical supervision.